Cubist Systematic Strategies, LLC Stryker Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$315.94 - $371.96 $284,346 - $334,764	-900 Reduced 50.0%	900 $325,000
Q2 2024 Aug 14, 2024	BUY	$324.3 - $354.67 $421,590 - $461,071	1,300 Added 260.0%	1,800 $612,000
Q1 2024 May 15, 2024	BUY	$293.94 - $358.71 $29,394 - $35,871	100 Added 25.0%	500 $178,000
Q4 2023 Feb 14, 2024	SELL	$253.85 - $299.46 $609,240 - $718,704	-2,400 Reduced 85.71%	400 $119,000
Q3 2023 Nov 14, 2023	SELL	$266.54 - $302.43 $1.04 Million - $1.18 Million	-3,900 Reduced 58.21%	2,800 $765,000
Q2 2023 Aug 14, 2023	SELL	$271.49 - $305.09 $162,894 - $183,053	-600 Reduced 8.22%	6,700 $2.04 Million
Q1 2023 May 15, 2023	BUY	$246.13 - $285.47 $123,065 - $142,735	500 Added 7.35%	7,300 $2.08 Million
Q3 2022 Nov 14, 2022	BUY	$189.27 - $231.83 $1.29 Million - $1.58 Million	6,800 New	6,800 $1.38 Million

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $137B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.